Queens Cancer Center Minority-Based Community Clincal Oncology Program

皇后区癌症中心少数族裔社区临床肿瘤学项目

• 批准号: 7892625
• 负责人: Margaret margaret Kemeny
• 金额: $ 48.01万
• 依托单位: QUEENS HOSPITAL CENTER
• 依托单位国家: 美国
• 财政年份: 2010
• 资助国家: 美国
• 起止时间: 2010-09-01 至 2013-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7892625
• 关键词: Arts; Cancer Center; Cancer Control; Caring; Clinical; Clinical Trials; Communities; Community Clinical Oncology Program; Community Health Education; Comprehensive Cancer Center; Diagnostic Neoplasm Staging; Disease; Early Diagnosis; Economics; Grant; Health; Health care facility; Hospitals; Immigrant; Insurance; Minority; Minority Groups; Minority-Based Community Clinical Oncology Program; Mission; New York City; Outcome; Patients; Population; Prevention; Public Hospitals; Qualifying; Recording of previous events; Research; Research Infrastructure; Staging; System; Uninsured; base; cancer care; cancer therapy; control trial; improved; outreach; patient population; programs; social; treatment trial

DESCRIPTION (provided by applicant): The Queens Cancer Center (QCC) is uniquely qualified to become a Minority Based Community Clinical Oncology Program. QCC is part of the Queens Health Network (QHN) which is comprised of the only two public hospitals in Queens, Queens Hospital Center (QHC) and Elmhurst Hospital Center (EHC). The public hospital system of New York City provides care for a population composed almost entirely of patients from minority groups, lower economic social strata, and the uninsured. These are the very patients that this minority based CCOP RFA is targeting. Since its inception in 2002, the QCC has been dedicated to bringing the best possible cancer care to the people in Queens who were previously underserved, including minority patients, recent immigrants and patients without insurance or means. It is the only clinical comprehensive cancer center within the public hospital system of all of New York City. The population served by the Queens Health Network has an unfortunate history of late stage cancers of all kinds and poorer survival. The mission of the QCC is to reduce the rates of late stage disease and to improve the care for cancer. The strategies to accomplish this include education of the community, introduction of cancer control trials, outreach for early detection programs and state of the art cancer care including access to clinical cancer treatment trials. The patient population in the Queens Health Network is overwhelmingly from minority groups. These are the patients who do not have access to clinical trials. The Queens Health Network is the only health facility in Queens, a borough with more than 2 million people that offers access to multi-institutional treatment trials. The organization is already in place to offer some trials, but more staff is needed to expand this effort to a larger population. The purpose of this grant is to establish a minority base CCOP in the Queens Health Network so that more patients can be given access to cancer control and treatment trials. RELEVANCE: Research in cancer control, prevention, early detection and treatment has not been offered equally to minority patients; perhaps resulting in later stage disease at presentation and worse outcomes. It is essential that the NCI support public hospital systems such as ours, with a proven track record in research, to enhance their infrastructure so that disparities in cancer care for these communities can be reduced.

描述（由申请人提供）：皇后区癌症中心（QCC）是唯一有资格成为少数民族社区临床肿瘤学计划。QCC是皇后区健康网络（QHN）的一部分，该网络由皇后区仅有的两家公立医院皇后区医院中心（QHC）和埃尔姆赫斯特医院中心（EHC）组成。纽约市的公立医院系统为几乎完全由少数群体、较低经济社会阶层和没有保险的病人组成的人口提供护理。这些正是这种基于少数群体的CCOP RFA的目标患者。自2002年成立以来，QCC一直致力于为皇后区以前服务不足的人提供最好的癌症护理，包括少数民族患者，最近的移民和没有保险或手段的患者。它是纽约市公立医院系统中唯一的临床综合癌症中心。皇后区健康网络所服务的人群有各种晚期癌症和生存率较低的不幸历史。QCC的使命是降低晚期疾病的发生率，改善癌症的护理。实现这一目标的战略包括社区教育、引入癌症控制试验、早期发现方案的推广和最先进的癌症护理，包括获得临床癌症治疗试验。皇后区卫生网络的患者绝大多数来自少数群体。这些患者无法参加临床试验。皇后区卫生网络是皇后区唯一的卫生设施，皇后区拥有200多万人口，提供多机构治疗试验。该组织已经到位，提供一些试验，但需要更多的工作人员来扩大这一努力，以更大的人口。这笔赠款的目的是在皇后区卫生网络中建立一个少数族裔基础的CCOP，以便更多的患者能够获得癌症控制和治疗试验。 相关性：癌症控制、预防、早期发现和治疗方面的研究没有平等地提供给少数群体患者;这可能导致疾病晚期和更差的结果。至关重要的是，NCI支持像我们这样的公立医院系统，在研究方面有着良好的记录，以加强其基础设施，从而减少这些社区在癌症护理方面的差距。